4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001957554-26-000003
Chief Financial Officer gave up 26,645 shares (to pay taxes)
- Chief Financial Officer acquired 94,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Balthaser Kevin · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-31 | Exercise or conversion : show line 1 in the form | +73,750 | 166,358 | D | ||
| 2025-12-31 | Shares withheld for taxes : show line 2 in the form | −19,934 | $3.01 | $60,001 | 146,424 | D |
| 2026-01-01 | Exercise or conversion : show line 3 in the form | +7,500 | 153,924 | D | ||
| 2026-01-01 | Shares withheld for taxes : show line 4 in the form | −2,250 | $3.01 | $6,773 | 151,674 | D |
| 2026-01-02 | Exercise or conversion : show line 5 in the form | +13,200 | 164,874 | D | ||
| 2026-01-02 | Shares withheld for taxes : show line 6 in the form | −4,461 | $2.88 | $12,848 | 160,413 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-31 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −73,750 | 0 | D |
| 2026-01-01 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −7,500 | 7,500 | D |
| 2026-01-02 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −13,200 | 13,600 | D |
Loading xslF345X05/form4-01052026_090132.xml…